LSM-775
lysergic acid morpholide
1Provenance card
the boundary, as counts
Sources
2316 with DOI
4 strong · 16 moderate · 3 weak
Compilations
12026-05-11T09:34:30.593Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
31last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:32:33.431Z
notice · info card · emergency
Searches
213 with no results
queries and counts on the build
Claims checked
7546 supported
46 supported · 29 not
Correspondence
0received
consent field ships in Phase 4
Edges
242
derivations recorded for this entity
Complete over 23 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/lsm-775/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-07srcReturn of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)
- 2026-09-07srcReturn of the lysergamides. Part III: Analytical characterization of ETH-LAD and 1P-ETH-LAD
- 2026-09-07srcReturn of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)
- 2026-09-07srcReturn of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)
- 2026-09-07srcPharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration
- 2026-09-07srcA Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD
- 2026-09-07srcBiosynthesis, total synthesis, and biological profiles of Ergot alkaloids
- 2026-09-07srcCrystal Structure of an LSD-Bound Human Serotonin Receptor
- 2026-09-07srcDetermination of LSD and its metabolites in human biological fluids by HPLC-MS/MS
- 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-07srcAcute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
- 2026-09-07srcStructural pharmacology and therapeutic potential of 5-methoxytryptamines.
- 2026-09-07srcGenetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
- 2026-09-07srcPsychedelics
- 2026-09-07srcDifferential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
- 2026-09-07srcConcomitant use of antidepressants and classic psychedelics: A scoping review
- 2026-09-07srcLysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD)
- 2026-09-07srcPharmacology of d-lysergic acid morpholide (LSM)
- 2026-09-07srcTranscriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
- 2026-09-07srcTramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
- 2026-09-07srcLSM-775 legal status and pharmacology
- 2026-09-07srcLSM-775 dosage and effects
- 2026-09-07srcLSM-775 Erowid Experience Report: The Most Unique Lysergamide I've Tried
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-11revisionRevision 1
- 2026-05-11absenceSearched ClinicalTrials.gov for "LSM-775" — no results
- 2026-05-11absenceSearched PubMed for "LSM-775 lysergamide morpholine" — no results
- 2026-05-11absenceSearched PubChem for "LSM-775" — no results
- 2026-05-11genGeneration — pipeline-v5 · with 7 morepipeline-v5
- 2026-05-11rungeneration run
The same entries, as forms: six forms.